Elevar Therapeutics
Jacki Dillingham is a seasoned clinical trial manager with extensive experience in the pharmaceutical industry, currently serving as a Sr. Clinical Trial Manager at Elevar Therapeutics since April 2024. Prior to this role, Jacki held positions at Taiho Oncology, Inc. as a Senior Study Manager in early 2024, and at Astex Pharmaceuticals, Inc. from September 2015 to January 2024, where responsibilities included managing oncology-focused clinical trials as a Team Lead. Earlier experience includes roles at Genentech, where Jacki supported multiple clinical trials, and Synarc, managing timelines and deliverables for imaging in clinical research. Educational qualifications include a B.S. in Biology, specializing in Molecular and Cellular Biology, from California Polytechnic State University-San Luis Obispo.
This person is not in any teams
This person is not in any offices
Elevar Therapeutics
Elevar Therapeutics is a pharmaceutical company that specializes in the development of therapies for unmet medical needs in cancer. The company is developing two proprietary drug candidates; rivoceranib (Apatinib), a VEGFR-2 inhibitor which has demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with thepotential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent.Elevar Therapeutics holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing in South Korea.